CANOMAD syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:71279G61.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

CANOMAD syndrome is a very rare nerve disorder. The name stands for Chronic Ataxic Neuropathy, Ophthalmoplegia, M-protein, cold Agglutinins, and Disialosyl antibodies — which describes the main features doctors look for. It is sometimes called CANOMAD neuropathy. The condition belongs to a group of diseases where the immune system mistakenly attacks the nerves, particularly the nerves that control balance, movement, and eye muscles. In CANOMAD, the body produces abnormal proteins (called IgM antibodies) that target specific sugar molecules on nerve cells called disialosyl gangliosides. This attack damages the nerves over time, leading to problems with coordination, balance, and eye movement. Many people also have a blood abnormality called cold agglutinins, where red blood cells clump together in cold temperatures. The main symptoms include unsteady walking, double vision, drooping eyelids, difficulty swallowing, and weakness or numbness in the limbs. The disease usually progresses slowly but can cause significant disability. Treatment focuses on calming the immune system using therapies like intravenous immunoglobulin (IVIg), rituximab, or plasma exchange. There is no cure, but many patients respond well to immune-based treatments, which can slow or partially reverse symptoms.

Also known as:

Key symptoms:

Unsteady walking and poor balance (ataxia)Double vision or blurred visionDrooping eyelids (ptosis)Difficulty moving the eyes (ophthalmoplegia)Numbness or tingling in the hands and feetWeakness in the arms or legsDifficulty swallowing (dysphagia)Slurred speechReduced or absent reflexesSensitivity to cold temperaturesFatigue and low energyRaynaud's phenomenon (fingers turning white or blue in the cold)

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for CANOMAD syndrome.

View clinical trials →

No actively recruiting trials found for CANOMAD syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the CANOMAD syndrome community →

No specialists are currently listed for CANOMAD syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to CANOMAD syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open CANOMAD syndromeForum →

No community posts yet. Be the first to share your experience with CANOMAD syndrome.

Start the conversation →

Latest news about CANOMAD syndrome

No recent news articles for CANOMAD syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which treatment do you recommend for me first, and how will we know if it is working?,How often will I need IVIg infusions or other treatments, and for how long?,What signs should prompt me to seek emergency care?,Are there any clinical trials for CANOMAD that I might be eligible for?,How should I protect myself from cold temperatures given my cold agglutinins?,Should I see a hematologist in addition to a neurologist?,What rehabilitation services, such as physiotherapy or occupational therapy, would help me manage my symptoms?

Common questions about CANOMAD syndrome

What is CANOMAD syndrome?

CANOMAD syndrome is a very rare nerve disorder. The name stands for Chronic Ataxic Neuropathy, Ophthalmoplegia, M-protein, cold Agglutinins, and Disialosyl antibodies — which describes the main features doctors look for. It is sometimes called CANOMAD neuropathy. The condition belongs to a group of diseases where the immune system mistakenly attacks the nerves, particularly the nerves that control balance, movement, and eye muscles. In CANOMAD, the body produces abnormal proteins (called IgM antibodies) that target specific sugar molecules on nerve cells called disialosyl gangliosides. This a

How is CANOMAD syndrome inherited?

CANOMAD syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does CANOMAD syndrome typically begin?

Typical onset of CANOMAD syndrome is adult. Age of onset can vary across affected individuals.